BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) is a publicly traded Healthcare sector company. As of May 21, 2026, BRTX trades at $0.18 with a market cap of $4.75M and a P/E ratio of -0.11. BRTX moved -7.84% today. Year to date, BRTX is -85.80%; over the trailing twelve months it is -89.15%. Its 52-week range spans $0.16 to $2.55. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces BRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BRTX moved -7.84% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $0.18 |
| Market Cap | $4.75M |
| P/E Ratio | -0.11 |
| EPS | $-1.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.55 |
| 52-Week Low | $0.16 |
| Volume | 58.12K |
| Avg Volume | 0 |
| Revenue (TTM) | $359.70K |
| Net Income | $-14.24M |
| Gross Margin | 93.37% |
2 analysts cover BRTX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.